Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages

Susan B Gurley1, Thomas M Coffman

  • 1Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, NC, USA.

Insights

Investigating angiotensin-converting enzyme 2 (ACE2) knockout mice reveals varied cardiovascular phenotypes. This review compares distinct ACE2-null mouse lines to clarify ACE2

Area of Science:

  • Physiology
  • Cardiovascular Science
  • Endocrinology

Background:

  • The renin-angiotensin system (RAS) is crucial for blood pressure regulation.
  • Angiotensin-converting enzyme 2 (ACE2) is a recently identified component of the RAS.
  • Understanding ACE2's physiological role is essential.

Purpose of the Study:

  • To review and compare published studies utilizing ACE2-null mouse lines.
  • To highlight discrepancies in reported cardiovascular phenotypes among different ACE2 knockout models.
  • To synthesize findings regarding the physiological functions of ACE2.

Main Methods:

  • Generation of ACE2-null mouse lines via homologous recombination in embryonic stem cells.
  • Analysis of phenotypes, particularly cardiovascular physiology, across distinct ACE2 knockout models.
  • Literature review of experimental results from different investigative groups.

Main Results:

  • Multiple ACE2 knockout mouse lines have been generated by different research groups.
  • Significant variations exist in the reported cardiovascular phenotypes of these distinct lines.
  • Comparison of these lines aids in understanding ACE2's complex physiological roles.

Conclusions:

  • ACE2-null mouse models provide valuable insights into the physiological functions of ACE2.
  • Discrepancies in phenotypes underscore the need for careful interpretation of knockout mouse data.
  • Further research is needed to fully elucidate the role of ACE2 in cardiovascular homeostasis.